Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
For athletes, bodybuilders, and active adults who have been watching the injectable GLP-1 phenomenon from the sidelines, concerned about needles, muscle loss, or the commitment of weekly injections, this is a pivotal moment
small human dermatology studies report increases in collagen synthesis and reductions in wrinkle depth over 812 weeks. Phase 1: Activation (Weeks 14) Dose: 3.2 mg daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells KPV simultaneously suppresses inflammatory interference Expected: Skin hydration improves, tone evens, texture softens, redness decreases
A landmark study published in the International Journal of Cosmetic Science (Lintner and Peschard, 2000) demonstrated that Pal-KTTKS at 10 ppm concentration increased collagen I synthesis by approximately 65% in fibroblast cultures
GLP-1 medications like Tirzepatide and Semaglutide are highly effective for fat loss, but they do not preserve muscle
Most patients experience their first symptoms within 3 to 7 days of injection, though timing varies based on individual metabolism, starting dose, and genetic factors affecting peptide sensitivity
More research is needed to understand its long-term effects and safety
